Scancell Holdings (SCLP) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 May 2014 08:30 AM
RNS
Directorate Change
01 May 2014 07:00 AM
RNS
Dr Sally Adams to Join as Development Director
04 Apr 2014 07:00 AM
RNS
Scancell to present SCIB1 at AACR
21 Mar 2014 07:00 AM
RNS
8mg Higher Dose SCIB1 Study On Track
18 Feb 2014 07:00 AM
RNS
Publication of Moditope Patent
11 Feb 2014 07:00 AM
RNS
SCIB1 Granted FDA Orphan Drug Status
10 Feb 2014 04:43 PM
RNS
Holding(s) in Company
06 Jan 2014 07:00 AM
RNS
Nottingham Technology Grant
16 Dec 2013 07:00 AM
RNS
Nottingham Trent University Cancer Protein Study
12 Dec 2013 07:00 AM
RNS
DNA ImmunoBody Patent Granted in Japan
11 Dec 2013 07:00 AM
RNS
Director/PDMR Shareholding
09 Dec 2013 07:00 AM
RNS
New data for SCIB1 in metastatic melanoma
09 Dec 2013 07:00 AM
RNS
Half Yearly Report
18 Nov 2013 07:00 AM
RNS
Re Agreement with Ichor
01 Nov 2013 04:56 PM
RNS
AGM Statement
22 Oct 2013 08:00 AM
RNS
Director/PDMR Shareholding
14 Oct 2013 10:10 AM
RNS
Holding(s) in Company
08 Oct 2013 02:54 PM
RNS
Notice of AGM
01 Oct 2013 07:00 AM
RNS
Investor Update
24 Sep 2013 07:00 AM
RNS
Investor Update Agenda
10 Sep 2013 03:06 PM
RNS
Investor Day
03 Sep 2013 07:00 AM
RNS
DNA ImmunoBody Patent Granted in first market
20 Aug 2013 07:00 AM
RNS
Inclusion on Frankfurt Stock Exchange
12 Aug 2013 05:16 PM
RNS
Director/PDMR Shareholding
08 Aug 2013 03:15 PM
RNS
Holding(s) in Company
05 Aug 2013 02:17 PM
RNS
Holding(s) in Company
01 Aug 2013 11:39 AM
RNS
Result of General Meeting
26 Jul 2013 07:00 AM
RNS
Result of Open Offer
23 Jul 2013 07:00 AM
RNS
Director/PDMR Shareholding
19 Jul 2013 04:40 PM
RNS
Second Price Monitoring Extn
19 Jul 2013 04:35 PM
RNS
Price Monitoring Extension
12 Jul 2013 07:00 AM
RNS
Research Update
10 Jul 2013 10:55 AM
RNS
Annual Financial Report
09 Jul 2013 07:00 AM
RNS
Proposed Firm Placing and Open Offer
09 Jul 2013 07:00 AM
RNS
Final Results
09 Apr 2013 07:00 AM
RNS
Appointment of Non-Executive Director
14 Mar 2013 07:00 AM
RNS
Re: The Journal of Clinical Investigation Paper
27 Feb 2013 02:00 PM
RNS
Directorate Change
06 Feb 2013 07:00 AM
RNS
ImmunoBody patent approved for grant in Japan
31 Jan 2013 07:00 AM
RNS
Half Yearly Report
29 Jan 2013 07:00 AM
RNS
Update on patient recruitment in clinical trial
12 Dec 2012 07:00 AM
RNS
Directorate Change
12 Dec 2012 07:00 AM
RNS
SCIB1 Trial-Higher Dose Allowed in Phase 1/2 Trial
06 Dec 2012 07:00 AM
RNS
Update on SCIB1 Phase 1/2 clinical trial
03 Dec 2012 09:30 AM
RNS
Holding(s) in Company
07 Nov 2012 04:02 PM
RNS
Result of AGM
12 Oct 2012 07:00 AM
RNS
Final Results
08 Oct 2012 10:43 AM
RNS
Holding(s) in Company
08 Oct 2012 10:43 AM
RNS
Holding(s) in Company
08 Oct 2012 10:31 AM
RNS
Notice of Results and Share Price Movement

Scancell Holdings PLC is a biopharmaceutical company that develops vaccines and other therapies to treat cancer and infectious diseases. Scancell's research focuses on the human immune system and how to use it to develop new treatments. Scancell uses four technology platforms to develop its products: ImmunoBody, Moditope, GlyMab and AvidiMab.

Scancell was founded in 1997 based on research led by Professor Lindy Durrant at the University of Nottingham.

Scancell Holdings PLC is listed on the London Stock Exchange (LSE) as SCLP.

Scancell share price listed at 8p in 2010.

UK 100

Latest directors dealings